Clinical Trial Update: Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing 4RIF versus 9INH for treatment of latent tuberculosis infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection

Drugs mentioned

• 4RIF (rifampin-based regimen)
• 9INH (isoniazid-based regimen)

Snippet

Sponsor: McGill University | Conditions: Latent Tuberculosis Infection | Phase 3 | Status: COMPLETED